Two Sigma Investments LP Sells 17,811 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Two Sigma Investments LP reduced its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 61.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 11,006 shares of the technology company's stock after selling 17,811 shares during the quarter. Two Sigma Investments LP owned 0.05% of Simulations Plus worth $307,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of SLP. Ameriprise Financial Inc. raised its position in Simulations Plus by 16.7% during the fourth quarter. Ameriprise Financial Inc. now owns 607,902 shares of the technology company's stock valued at $16,954,000 after purchasing an additional 86,868 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Simulations Plus by 7,753.3% during the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock worth $15,141,000 after buying an additional 535,986 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Simulations Plus by 6.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 419,241 shares of the technology company's stock worth $11,693,000 after buying an additional 24,266 shares during the last quarter. Royce & Associates LP lifted its position in shares of Simulations Plus by 56.6% during the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock worth $10,369,000 after buying an additional 134,381 shares during the last quarter. Finally, Kennedy Capital Management LLC boosted its stake in Simulations Plus by 59.4% in the fourth quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company's stock valued at $8,068,000 after buying an additional 107,766 shares in the last quarter. Institutional investors own 78.08% of the company's stock.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the transaction, the director now owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. This trade represents a 0.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 19.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Tuesday, June 3rd. KeyCorp increased their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. Finally, Wall Street Zen upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Simulations Plus currently has an average rating of "Moderate Buy" and a consensus target price of $50.00.

Simulations Plus Stock Performance

Shares of Simulations Plus stock traded down $6.14 on Thursday, hitting $20.30. The stock had a trading volume of 870,534 shares, compared to its average volume of 230,718. The stock has a 50 day moving average of $30.84 and a 200 day moving average of $30.31. The firm has a market capitalization of $408.25 million, a P/E ratio of 50.75 and a beta of 0.97. Simulations Plus, Inc. has a twelve month low of $19.75 and a twelve month high of $50.11.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The firm had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The company's revenue for the quarter was up 22.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.20 EPS. Equities analysts expect that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.